轮状病毒疫苗对东非和南部非洲国家轮状病毒腹泻的影响
基于世界卫生组织东非和南部非洲次区域14国2010至2015年哨点医院5岁以下腹泻住院儿童监测数据,2013年或之前引入轮状病毒疫苗的国家疫苗覆盖率从2010至2011年的0%升至2015年的90%,轮状病毒阳性率从2010年的35%降至2015年的19%;未引入国家同期覆盖率较低,阳性率从2010年的44%降至2015年的25%,且2013至2015年阳性率高于已引入国家。
要点
- 2013年或之前引入轮状病毒疫苗的国家,2010至2015年疫苗覆盖率从0%升至90%。
- 已引入国家轮状病毒阳性率从2010年35%降至2015年19%。
- 未引入国家2013至2015年轮状病毒阳性率高于已引入国家。
核心结论
- 2013年或之前引入轮状病毒疫苗的国家2013至2015年轮状病毒阳性住院比例低于未引入国家,轮状病毒阳性率下降与疫苗覆盖率上升呈负相关,显示轮状病毒疫苗的影响。
研究设计与样本
- 基于世界卫生组织东非和南部非洲次区域14国哨点医院2010至2015年5岁以下急性腹泻住院儿童的哨点监测,粪便样本用酶免疫法检测轮状病毒抗原,比较已引入与未引入疫苗国家的阳性率趋势。
主要发现
- 2013年或之前引入疫苗国家(卢旺达、坦桑尼亚、赞比亚、埃塞俄比亚)平均疫苗覆盖率从2010和2011年的0%、2012年13%、2013年46%、2014年83%升至2015年90%。
- 已引入国家2010至2015年年度平均轮状病毒阳性率分别为35%、33%、38%、28%、27%、19%。
- 2013年后引入或2015年仍未引入国家平均疫苗覆盖率2010至2013年为0%、2014年13%、2015年51%。
- 未引入国家2010至2015年轮状病毒阳性率分别为44%、32%、33%、41%、40%、25%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Established in 2006 with four countries conducting hospital-based rotavirus surveillance, the African rotavirus surveillance network has expanded over subsequent years. By 2015, 14 countries in the World Health Organization (WHO) East and Southern Africa sub-region (Eritrea, Ethiopia, Kenya, Lesotho, Madagascar, Mauritius, Namibia, Rwanda, Seychelles, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe) were participating in the rotavirus surveillance network coordinated by WHO. We monitored the proportion of rotavirus diarrhoea among children under five years of age who were hospitalized for diarrhoea in the sentinel hospitals from 2010 to 2015 among countries that introduced rotavirus vaccine during or before 2013 (Rwanda, Tanzania, Zambia and Ethiopia) and compared with the other countries in the network. METHODS: Children under the age of five years hospitalized due to acute diarrhoea were enrolled into the sentinel surveillance system and had stool samples collected and tested for rotavirus antigens by enzyme immunoassay. We described trends in rotavirus positivity among tested stool samples before and after rotavirus vaccine introduction. RESULTS: In countries that introduced rotavirus vaccine by 2013 (Rwanda, Tanzania, Zambia and Ethiopia), average rotavirus vaccine coverage from 2010 to 2015 improved from 0% in 2010 and 2011, 13% in 2012, 46% in 2013, 83% in 2014 to 90% in 2015. Annual average rotavirus positivity from 2010 to 2015 was 35%, 33%, 38%, 28%, 27%, and 19%, respectively. In countries that introduced rotavirus vaccine after 2013 or had not introduced by 2015, average rotavirus vaccine coverage was 0% in 2010-2013, 13% in 2014 and 51% in 2015. In these countries, rotavirus positivity was 44% in 2010, 32% in 2011, 33% in 2012, 41% in 2013, 40% in 2014 and 25% in 2015. CONCLUSION: Countries that introduced rotavirus vaccine by 2013 had a lower proportion of rotavirus positive hospitalizations in 2013-2015 as compared to those that had not introduced rotavirus vaccine by 2013. The decrease in rotavirus positivity was inversely related to increase in rotavirus vaccine coverage showing impact of rotavirus vaccines.
引用
- Weldegebriel G, Mwenda JM, Chakauya J, et al. Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa. Vaccine. 2017. PMID: 29102168. doi:10.1016/j.vaccine.2017.10.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。